PARSIDOL Drug Patent Profile
✉ Email this page to a colleague
When do Parsidol patents expire, and when can generic versions of Parsidol launch?
Parsidol is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in PARSIDOL is ethopropazine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the ethopropazine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PARSIDOL?
- What are the global sales for PARSIDOL?
- What is Average Wholesale Price for PARSIDOL?
Summary for PARSIDOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 5,281 |
| DailyMed Link: | PARSIDOL at DailyMed |
US Patents and Regulatory Information for PARSIDOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | PARSIDOL | ethopropazine hydrochloride | TABLET;ORAL | 009078-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parke Davis | PARSIDOL | ethopropazine hydrochloride | TABLET;ORAL | 009078-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parke Davis | PARSIDOL | ethopropazine hydrochloride | TABLET;ORAL | 009078-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
